Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1989;104(3):187–196. doi: 10.1007/BF01315542

Virus strain specificity of challenge immunity to coronavirus

S W Barthold 1, Abigail L Smith 1
PMCID: PMC7086909  PMID: 2468325

Summary

The resistance of immunized mice to challenge with the same or a different strain of mouse hepatitis virus (MHV) was examined as a model of challenge immunity to coronavirus infection. Genetically susceptible BALB/cByJ mice were given an intranasal immunizing infection of respiratory-type MHV-JHM, MHV-S, or enterotropic MHV-Y. Control mice were sham-immunized with sterile tissue culture fluid. Recovered mice were challenged intranasally with MHV-JHM, MHV-S or sterile tissue culture fluid at 30 days after immunization. Resistance to challenge inoculation was evaluated in groups of mice at 4 and 30 days after challenge. At 4 days, the prevalence of MHV lesions in nose and liver was tabulated and MHV titers in liver were determined. At 30 days, the prevalence of residual brainstem spongiform lesions was tabulated and serum antibody to MHV-JHM and MVH-S was quantified by enzyme immunoassay. Mice immunized with MHV-JHM or MHV-S resisted challenge with the MHV homotype, but MHV-S-immunized mice were fully susceptible to challenge with MVH-JHM. Mice immunized with enterotropic MHV-Y were only partially protected against challenge with antigenically related, but biologically different MHV-S. Serum antibody responses to MHV supported these observations. These data indicate that challenge immunity to coronaviruses is strong, but highly virus strain-specific.

Keywords: Hepatitis, Infectious Disease, Control Mouse, Antibody Response, Virus Strain

References

  • 1.Barthold SW. Mouse hepatitis virus biology and epizootiology. In: Bhatt PN, Jacoby RO, Morse AC III, New AE, editors. Viral and mycoplasmal infections of laboratory rodents: effects on biomedical research. Orlando, FL: Academic Press; 1986. pp. 571–601. [Google Scholar]
  • 2.Barthold SW. Host age and genotypic effects on enterotropic mouse hepatitis virus infection. Lab Anim Sci. 1987;37:36–40. [PubMed] [Google Scholar]
  • 3.Barthold SW. Olfactory neural pathway in mouse hepatitis virus nasoencephalitis. Acta Neuropathol. 1988;76:502–506. doi: 10.1007/BF00686390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Barthold SW, Beck DS, Smith AL. Mouse hepatitis virus nasoencephalopathy is dependent upon virus strain and host genotype. Arch Virol. 1986;91:247–256. doi: 10.1007/BF01314284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Barthold SW, Smith AL. Mouse hepatitis virus S in weanling Swiss mice following intranasal inoculation. Lab Anim Sci. 1983;33:355–360. [PubMed] [Google Scholar]
  • 6.Barthold SW, Smith AL. Mouse hepatitis virus strain-related patterns of tissue tropism in suckling mice. Arch Virol. 1984;81:103–112. doi: 10.1007/BF01309300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Barthold Sw, Smith AL. Response of genetically susceptible and resistant mice to intranasal inoculation with mouse hepatitis virus JHM. Virus Res. 1987;7:225–239. doi: 10.1016/0168-1702(87)90030-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Barthold SW, Smith AL, Lord PFS, Bhatt PN, Jacoby RO, Main AJ. Epizootic coronaviral typhlocolitis in suckling mice. Lab Anim Sci. 1982;32:376–383. [PubMed] [Google Scholar]
  • 9.Buchmeier MJ, Lewicki HA, Talbot PJ, Knobler RC. Murine hepatitis virus-4(strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibodies. Virology. 1984;132:261–270. doi: 10.1016/0042-6822(84)90033-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Collins AR, Knobler RL, Powell H, Buchmeier MJ. Monoclonal antibodies to murine hepatitis virus-4(strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion. Virology. 1982;119:358–371. doi: 10.1016/0042-6822(82)90095-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Dalziel RG, Lamper PW, Talbot PJ, Buchmeier MJ. Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E 2 results in reduced neurovirulence. J Virol. 1986;59:463–471. doi: 10.1128/jvi.59.2.463-471.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Dick G, Niven J, Gledhill A. A virus related to that causing hepatitis in mice (MHV) Br J Exp Pathol. 1956;27:90–98. [PMC free article] [PubMed] [Google Scholar]
  • 13.Fleming JO, Stohlman SA, Harmon RC, Lai MMC, Frelinger JA, Weiner LP. Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology. 1983;131:296–307. doi: 10.1016/0042-6822(83)90498-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Garlinghouse LE, Smith AL. Responses of mice susceptible or resistant to lethal infection with mouse hepatitis virus, strain JHM, after exposure by a natural route. Lab Anim Sci. 1985;35:469–472. [PubMed] [Google Scholar]
  • 15.Hierholzer JC, Broderson JR, Murphy FA. New strain of mouse hepatitis virus as the cause of lethal enteritis in infant mice. Infect Immun. 1979;24:508–522. doi: 10.1128/iai.24.2.508-522.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Holmes KV. Replication of coronaviruses. In: Fields BN, Knipe DM, Chanock RM, Melnick JL, Roizman B, Shope RE, editors. Fundamental virology. New York: Raven Press; 1986. pp. 513–525. [Google Scholar]
  • 17.Keck JG, Makino S, Soe LH, Fleming JO, Stohlman SA, Lai MMC. RNA recombination of coronavirus. Adv Exp Med Biol. 1987;218:99–107. doi: 10.1007/978-1-4684-1280-2_11. [DOI] [PubMed] [Google Scholar]
  • 18.Nakanaga K, Yamanouchi K, Fujiwara K. Protective effect of monoclonal antibodies on lethal mouse hepatitis virus infection in mice. J Virol. 1986;59:168–171. doi: 10.1128/jvi.59.1.168-171.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Smith AL. An immunofluorescence test for detection of serum antibody to rodent coronaviruses. Lab Anim Sci. 1983;33:157–160. [PubMed] [Google Scholar]
  • 20.Smith AL, Barthold SW, Beck DS. Intranasally administered alpha/beta interferon prevents extension of mouse hepatitis virus, strain JHM, into the brains of BALB/cByJ mice. Antiviral Res. 1987;8:239–246. doi: 10.1016/S0166-3542(87)80002-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Smith AL, Winograd DF. Two enzyme immunoassays for detection of antibody to rodent coronaviruses. J Virol Methods. 1986;14:335–343. doi: 10.1016/0166-0934(86)90035-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Taguchi F, Goto Y, Aiuchi M, Hayashi T, Fujiwara K. Pathogenesis of mouse hepatitis virus infection. The role of nasal epithelial cells as a primary target of low-virulence virus, MHV-S. Microbiol Immunol. 1979;23:249–262. doi: 10.1111/j.1348-0421.1979.tb00461.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Taguchi F, Yamada A, Fujiwara K. Resistance to highly virulent mouse hepatitis virus acquired by mice after low-virulence infection: enhanced antiviral activity of macrophages. Infect Immun. 1980;29:42–49. doi: 10.1128/iai.29.1.42-49.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Talbot PJ, Buchmeier MJ. Antigenic variation among murine coronaviruses: evidence for polymorphism on the peplomer glycoprotein, E 2. Virus Res. 1985;2:317–328. doi: 10.1016/0168-1702(85)90028-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Wege H, Siddell S, ter Meulen V. The biology and pathogenesis of coronaviruses. Curr Top Microbiol Immunol. 1982;99:165–200. doi: 10.1007/978-3-642-68528-6_5. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Virology are provided here courtesy of Nature Publishing Group

RESOURCES